New offering assists physicians by delivering Bioflux devices directly to at-risk patients, helping them avoid in-office visits REDWOOD CITY, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the launch of […]
Tag: Bioflux
Biotricity Receives FDA clearance for Bioflux Software II System
The software significantly improves workflows for analysis, increasing efficiency and reducing costs REDWOOD CITY, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has received a 510(k) clearance from […]
Biotricity® Partners with Verizon to Develop EMS Solutions
Verizon to Integrate the Bioflux® Solution into their EMS and Launch to Existing and Future Customers REDWOOD CITY, Calif., July 14, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company announced a strategic partnership with Verizon […]
Biotricity’s Real-Time Monitoring Bioflux Device can Help Identify Life Threatening QT Prolongation in COVID-19 Patients
REDWOOD CITY, Calif., April 07, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that its Bioflux® units are designed for QT interval analysis, a section of the ECG, to identify serious risks like […]
Biotricity Completes Development of its ECG Patch Platform
Company Prepares for FDA Filing of New Device REDWOOD CITY, Calif., Dec. 04, 2019 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has completed development of its ECG patch platform. An extension of the company’s […]
Biotricity Actively Pursues Holter Market with Bioflux Product Offering
REDWOOD CITY, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will be actively pursuing the Holter market in addition to the MCT market with its Bioflux product offering, expanding its revenue […]
Biotricity Developing ECG Patch for Anticipated Q1 2019 Release
REDWOOD CITY, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it is developing “Biopatch,” an ECG patch which it hopes to release in Q1 2019. An extension of the […]
Biotricity’s Bioflux Named Best Remote Patient Monitoring Solution by MedTech Breakthrough
REDWOOD CITY, Calif., June 06, 2018 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced that its Bioflux device has won the prestigious MedTech Breakthrough Award 2018 for Best […]